ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -100.0% | 22,693 | +389.4% | 0.00% | -100.0% |
| Q1 2018 | $335,000 | -26.9% | 4,637 | -33.4% | 0.00% | -33.3% |
| Q4 2017 | $458,000 | +2594.1% | 6,961 | +300.7% | 0.00% | – |
| Q2 2016 | $17,000 | -34.6% | 1,737 | +14.1% | 0.00% | – |
| Q1 2016 | $26,000 | +4.0% | 1,523 | +35.3% | 0.00% | – |
| Q4 2015 | $25,000 | -30.6% | 1,126 | -25.4% | 0.00% | – |
| Q3 2015 | $36,000 | -7.7% | 1,510 | +217.9% | 0.00% | – |
| Q2 2015 | $39,000 | +34.5% | 475 | +54.2% | 0.00% | – |
| Q1 2015 | $29,000 | +141.7% | 308 | +3.4% | 0.00% | – |
| Q4 2014 | $12,000 | – | 298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |